Nuclear Medicine: Page 19

Radiopharm collaborates with Lantheus on theranostic agent

By AuntMinnie.com staff writers

Radiopharm Theranostics has entered a collaboration agreement with Lantheus to develop NM-01, a nanobody that can be labeled with radioisotopes to diagnose and treat tumors for theranostic applications.

August 3, 2022

Navidea highlights research on melanoma, oral cancer

By AuntMinnie.com staff writers

Radiopharmaceutical developer Navidea Biopharmaceuticals is directing attention to new research from Australia on the use of its technetium-99m tilmanocept radiopharmaceutical in patients with melanoma or oral cancer.

August 1, 2022

What's the best way to get students interested in nuclear medicine?

By Brian Casey

What can be done to boost interest in nuclear medicine among medical students? Piquing their interest could be as simple as conducting a 30-minute seminar early in their medical training, according to a study published July 22 in Academic Radiology.

July 26, 2022

ITM selects Marx as chief business officer

By AuntMinnie.com staff writers

German radiopharmaceutical developer ITM Isotope Technologies Munich has named Sebastian Marx, PhD, as its chief business officer.

July 24, 2022

NorthStar inks Ac-225 supply deal with Clovis

By AuntMinnie.com staff writers

NorthStar Medical Radioisotopes has signed a long-term supply agreement with Clovis Oncology for NorthStar's actinium-225 (Ac-225) therapeutic radioisotope.

July 20, 2022

Clarity completes recruitment for prostate cancer trial

By AuntMinnie.com staff writers

Australian radiopharmaceutical developer Clarity Pharmaceuticals has completed recruitment for a PET study of its theranostic agent with copper-based radioisotopes for treating patients with prostate cancer.

July 19, 2022

FDA clears Radialis PET imager

By AuntMinnie.com staff writers

The U.S. Food and Drug Administration (FDA) has cleared Radialis' PET Imager, a small footprint, organ-targeted device.

July 17, 2022

FDA to allow Bayer to import contrast media

By AuntMinnie.com staff writers

The U.S. Food and Drug Administration (FDA) will now allow Bayer to import a limited quantity of iopromide, initially intended for international markets, for U.S. customers.

July 17, 2022

Nuclear medicine sentiment improves with expectations for higher volume

By Davin Korstjens

Nuclear medicine procedure volumes are expected to increase in 2022, but reimbursement, revenue, and net income are expected to stay the same, according to IMV Medical Information Division's newly published 2022 Nuclear Medicine Market Outlook Report.

July 7, 2022

Mirion launches new brand for medical business units

By AuntMinnie.com staff writers

Mirion Technologies has launched a new brand called Mirion Medical that will now represent the company's Dosimetry Services, Sun Nuclear, CIRS, Biodex, and Capintec business units.

July 6, 2022

Jamaica gets first public nuclear medicine center

By AuntMinnie.com staff writers

Jamaica has opened the country's first public nuclear medicine center, at the University Hospital of the West Indies in Kingston, with a June 30 ceremony noting the support of the International Atomic Energy Agency.

July 5, 2022

Novartis restarts supply of Lutathera and Pluvicto

By AuntMinnie.com staff writers

Novartis has taken steps to resolve quality issues that halted production of its Lu-177 DOTATATE (Lutathera) and Lu-177-PSMA-617 (Pluvicto) radiopharmaceutical cancer therapies, yet the dip in supply is still affecting patients, their families, and care teams.

June 30, 2022

Previous Page

Page 19 of 438

Next Page